Activities

Pharmaceuticals

SANSHO develops pharmaceuticals based on the patents it has obtained on the intellectual property created jointly by the Human Welfare Science Endowed Research Division of Ochanomizu University (Professor Emeritus Kimiko Murofushi) and College of Pharmacy of Toho University (Professor Emeritus Fumio Kato). The aging phenomenon we are witnessing in the world population has led to a tendency of continued increase in the numbers of patients in areas such as osteoarthrosis, cancers, and infections. Faced with the current situation, we are focusing on these areas and pushing forward with our research and development of new low-molecular compounds.

Cosmetics

Cosmetics

Thanks to its multiple in vivo effects, including promotion of hyaluronan synthesis, cyclic phosphatidic acid (cPA) provides outstanding features to boost elasticity and moisture holding in the skin. We have commercialized cPA in the area of cosmetics as well, distributing it in the form of both material and finished products we have originally developed. cPA is marketed as a cosmetic ingredient based on cooperation agreements with manufacturers in and outside Japan. An original line of cosmetic products containing cPA (toning lotion, milky lotion, and liquid essence) has been placed on the market since July 2008, shortly after the foundation of the company. Our products have gained, since, a large number of repeat users.

Pharmaceuticals

Activities

Pharmaceuticals

Drug to Treat Osteoarthrosis Cyclic Phosphatidic Acid

Heat Shock Protein Inducer Steryl Glycoside

Drug to Treat Infections Macrolide Antibiotics

Antitumor Agent TELIN (Low-Molecular Organic Compound)

Cosmetics